SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending following news of its acquisition of Metsera, a weight-loss drug developer, for a potential $7.3 billion. While some see this as a strategic move to enter the growing obesity market, others question the timing and price, noting the competitive landscape. The community is actively discussing the implications for Pfizer's pipeline, potential competition with other GLP-1 drugs, and whether this will finally boost the undervalued stock.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending downwards, with community members discussing the impact of prediction markets and increased competition from platforms like Kalshi and Robinhood. Some traders are speculating about potential support levels and whether the company will adapt its strategy. Despite the bearish sentiment, some investors see the dip as a buying opportunity, citing the company's strong position in the sports betting sector.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy ($BE) is trending due to growing optimism surrounding its role in powering AI data centers, with the community discussing the potential for significant growth and high price targets. A recent application for fuel cells to power a large power plant in Wyoming, along with comments from the Energy Secretary about hydrogen's role in powering the grid, are driving bullish sentiment. Community members are noting the stock's momentum and discussing potential short squeezes given the high short interest.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around its vision of linking crypto with cannabis culture, emphasizing freedom and growth within the digital space. Discussions highlight its potential as a culture coin, with community members sharing positive sentiments and links to purchase on Pump.fun and Dexscreener. The coin is also drawing attention for its association with the broader cannabis sector.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending following the announcement of partnerships with OpenAI, Snowflake, and Nvidia to enhance its automation platform with advanced AI. Community members are actively discussing the potential impact of these partnerships on UiPath's market position and revenue growth, as well as comparing it to other AI stocks like Palantir. Despite positive news, some traders remain cautious, citing concerns about the CEO's stock sales and broader market conditions.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending amid discussions about upcoming earnings and a potential turnaround, with community members debating whether the stock can break out. Recent partnerships, such as the SKIMS collaboration, are generating buzz, while analysts weigh in on the impact of tariffs and competition. Some traders are also closely monitoring technical indicators and potential trading strategies around the stock.

Draganfly, Inc. engages in the manufacture and sale of commercial unmanned aerial vehicle systems and software serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Its products include quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, and software used for tracking, live streaming, and data collection. The firm also offers custom engineering, training, simulation consulting, as well as data and flight training services. The company was founded by Zenon Dragan and Christine Dragan in 1998 and is headquartered in Saskatoon, Canada.

Draganfly Inc

DPRO is trending due to news of the company being selected by the U.S. Army to supply drone systems, including manufacturing and training support at overseas facilities, though financial terms were not disclosed. The community is discussing the potential impact of this military contract, with some speculating about a possible short squeeze given the stock's high short interest. Bullish sentiment is fueled by the company's position in the growing drone warfare market, while others express concerns about potential offerings.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI.X is trending as the community emphasizes its significance as the tokenization of Satoshi Nakamoto, the pseudonymous creator of Bitcoin. Many believe it represents the ethos of the entire crypto industry, calling it a 'second chance at Bitcoin' and highlighting the 'We Are All Satoshi' movement. Discussions also revolve around its potential for growth and NFT integration.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending as the community discusses its potential following a partnership announcement, with some highlighting its undervalued status and strong buyback program. Despite positive news, skepticism remains around the stock's ability to sustain gains, with traders closely watching key resistance levels. Community members also point to buy-now-pay-later growth and potential partnerships.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

MRK is trending as investors react to potential impacts from new Trump administration policies around drug pricing and tariffs, with community members weighing the balance between consumer benefits and profit margin concerns. There is also discussion around Merck's pipeline and potential acquisitions, with some suggesting a bullish setup while others point to concerns about Keytruda's future exclusivity. The community is also analyzing potential M&A scenarios and the impact of cost-cutting measures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring

BAX launches FDA-cleared Connex 360 monitor, aiming to boost frontline care and streamline patient monitoring.

Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36.&nbsp;The analysts&nbsp;revised their view following Baxter’s weak&nbsp;second-quarter (Q2) results, which also included a trimmed 2025 outlook and a cautious commentary on 2026 growth.Adjusted earnings for the quarter were $0.59 per share, which missed the $0.61 consensus. Revenue of $2.81 billion slightly missed the $2.82 billion estimate. Baxter’s full-year guidance was also narrowed to $2.42 to $2.52 from $2.47 to $2.55.CFO Joel Grade pointed to ongoing softness in demand for IV fluids, which are used to deliver medications or nutrients directly into a patient’s bloodstream, as a major drag on performance. "While we never want to lower expectations, our overall objective is reducing the outlook to capture more of the potential downside risks."That softness stems from conservation practices implemented after Hurricane Helene damaged Baxter’s North Carolina production facility in 2024.&nbsp;While supply has since recovered, the company expects demand to remain about 20% below normal levels for the rest of 2025, which will continue to weigh on operating income and profit per share.Stifel noted that Baxter’s disappointing Q2 results, lowered full-year guidance, and 2026 outlook have left the firm “feeling that the path to reliably-consistent mid-single-digit sales growth and more-meaningful margin expansion could take longer than previously thought.”Additional pressure came from Baxter’s pharmaceuticals segment, where injectable drug sales declined 1% and anesthesia sales dropped by low double digits globally.&nbsp;The company also voluntarily halted shipments of its Novum IQ Large Volume Pump following reports of two deaths and multiple injuries.On the positive side, Baxter lowered its projected tariff impact for 2025 to $40 million, down from a previous estimate of $60 million to $70 million.Andrew Hider is set to take over as CEO in early September.On Stocktwits, retail sentiment for Baxter was ‘extremely bullish’ amid ‘high’ message volume.One user on Stocktwits&nbsp;opined that Baxter is a profitable company with potential tailwinds over the next six months.&nbsp;<stembedurl>https://stocktwits.com/Philholl/message/623509381</stembedurl>Another user said that they started a position in the stock, calling it “way oversold” following what they viewed as a minor earnings miss, adding that healthcare stocks have been under pressure lately but don’t expect that trend to last.<stembedurl>https://stocktwits.com/Dr_Van_Nostrend/message/623270580</stembedurl><a href="https://stocktwits.com/symbol/BAX">Baxter’s stock</a> has declined 25% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Baxter International logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Baxter Downgraded By Stifel On Soft Q2, Guidance Cut — But Retail Eyes A Rebound

Stifel warned that Baxter’s path to consistent growth and margin expansion may take longer than expected, pointing to a cautious 2026 outlook.

Equity

Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates

Baxter (BAX) delivered earnings and revenue surprises of -1.67% and -0.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down

Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.

Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Stay Ahead of the Game With Baxter (BAX) Q2 Earnings: Wall Street's Insights on Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.

InMode (INMD) Q2 Earnings and Revenues Beat Estimates

InMode (INMD) delivered earnings and revenue surprises of +9.30% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter?

BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.

Shares of Baxter International Inc. (BAX) fell over 2% on Monday morning after the medtech company announced that it has appointed Andrew Hider as president and chief executive officer.Hider will take up his responsibilities no later than Sept. 3 or at an earlier date after completing his current commitments at ATS Corporation (ATS), the company said. Hider has been serving as CEO of ATS, who providers automation solutions for companies including in the life sciences, food and beverage, and consumer products industries, since 2017.Prior to joining ATS, Hider served as president and CEO of the Taylor Made Group, LLC, and served in several leaderships roles at life sciences and diagnostics company Danaher Corporation.<a href="https://stocktwits.com/symbol/BAX">Baxter</a> has been without a permanent CEO since February when José E Almeida retired from his executive roles, including that of the CEO. Since then, Brent Shafer has been serving as chair and interim CEO of the company.Shafer will now transition to independent chair of the Baxter Board, the company said.In the first quarter of 2025, Baxter’s worldwide sales from continuing operations totalled about $2.63 billion, marking a growth of 5% year-on-year, after production at its North Cove manufacturing site was disrupted to the second half of 2024 following a flooding event caused by Hurricane Helene.In May, the company said that its inventory levels are restored.Net income per diluted share for the quarter came in at $0.55, on top of the company’s original guidance.The company also divested its kidney care business to investment firm Carlyle in January for $3.8 billion.On Stocktwits, retail sentiment around Baxter fell from ‘neutral’ to ‘bearish’ territory over the past 24 hours while message volume remained at ‘high’ levels.<figure class="image"><img style="aspect-ratio:628/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_07_at_11_19_00_AM_png_35e8069f75.webp" alt="BAX's Sentiment Meter and Message Volume as of 11:20 a.m. ET on July 7, 2025 | Source: Stocktwits" width="628" height="64"><figcaption>BAX's Sentiment Meter and Message Volume as of 11:20 a.m. ET on July 7, 2025 | Source: Stocktwits</figcaption></figure>BAX stock is up by about 4% this year but down by about 10% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/scott-bessent-to-meet-china-next-two-weeks/chFtFuwR5ft">Treasury Secretary Scott Bessent Says He Will Meet His Chinese Counterpart In The Next Two Weeks: ‘There Are Things For Us To Do Together’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Baxter Appoints Andrew Hider To Succeed Jose Almeida As CEO: Retail Sentiment Falters

Hider will take up his responsibilities no later than Sept. 3 or at an earlier date after completing his current commitments at ATS Corporation (ATS), Baxter said.

FMS Stock Likely to Gain on New Optimization Plan FME Reignite

Fresenius Medical Care unveils FME Reignite, targeting one billion euros in cost savings, tech upgrades and enhanced shareholder returns.

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Baxter International Inc.

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

BAX
Baxter International Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BAX News

BAX Baxter International Inc.